Latest News and Press Releases

NEW YORK, May 19, 2005 (PRIMEZONE) -- Advanced Plant Pharmaceuticals, Inc. (OTCBB:APPI) and its majority owned subsidiary, Mazal Plant Pharmaceuticals Inc., announced today that Mazal received...

NEW YORK, April 14, 2005 (PRIMEZONE) -- Advanced Plant Pharmaceuticals, Inc. (OTCBB:APPI) and its majority owned subsidiary, Mazal Plant Pharmaceuticals Inc., announced today that Mazal has filed an...

NEW YORK, March 1, 2005 (PRIMEZONE) -- David Lieberman, CEO of Advanced Plant Pharmaceuticals, Inc., (OTCBB:APPI) announced today the appointment of Dr. Mechael Kanovsky as President of Mazal Plant...

NEW YORK, Dec. 1, 2004 (PRIMEZONE) -- David Lieberman, CEO of Advanced Plant Pharmaceuticals, Inc., (OTCBB:APPI) confirmed today the closing of an asset sale agreement entered with Mazal Plant...

NEW YORK, Sept. 7, 2004 (PRIMEZONE) -- Advanced Plant Pharmaceuticals, Inc. ("APPI") (OTCBB:APPI), a company dedicated to the research, development and marketing of "whole plant" nutraceuticals and...

NEW YORK, Aug. 26, 2004 (PRIMEZONE) -- Advanced Plant Pharmaceuticals, Inc. ("APPI") (OTCBB:APPI) announced today that it has appointed Dr. Mechael Kanovsky to spearhead the Company's recently...

NEW YORK, Aug. 19, 2004 (PRIMEZONE) -- Advanced Plant Pharmaceuticals, Inc. ("APPI") (OTCBB:APPI), a company dedicated to the research, development and marketing of "whole plant" nutraceuticals and...

NEW YORK, June 3, 2004 (PRIMEZONE) -- Advanced Plant Pharmaceuticals, Inc. (OTCBB:APPI) announced today that it had successfully been delisted from the Berlin-Bremen Stock Exchange. The company had...

NEW YORK, April 15, 2004 (PRIMEZONE) -- Advanced Plant Pharmaceuticals, Inc. (OTCBB:APPI), a company that utilizes whole plants through a proprietary (patent pending) manufacturing process to develop...

NEW YORK, March 22, 2004 (PRIMEZONE) -- Advanced Plant Pharmaceuticals, Inc. (OTCBB:APPI) is pleased to announce that it has been listed on the Berlin Stock Exchange. The trading symbol on the Berlin...